ARCHIVES

Assurances On Methods For Misconduct Reporting Required

This article is from The Cancer Letter archive.

Vol. 15 No. 46 | December 1, 1989

Download PDF Visit The Full Archive

Related Articles

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010

NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings

January 17, 1986

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981